J P Morgan Chase & Co Reiterates Buy Rating for Roche Holding Ltd. (ROG)
Roche Holding Ltd. (VTX:ROG)‘s stock had its “buy” rating restated by research analysts at J P Morgan Chase & Co in a research note issued to investors on Monday.
A number of other research analysts have also commented on ROG. UBS AG set a CHF 260 price target on Roche Holding and gave the company a “neutral” rating in a research report on Thursday, July 6th. Citigroup Inc. reiterated a “buy” rating on shares of Roche Holding in a report on Wednesday, July 5th. Societe Generale set a CHF 275 price objective on Roche Holding and gave the stock a “neutral” rating in a research report on Thursday, June 29th. Deutsche Bank AG set a CHF 273 price objective on Roche Holding and gave the stock a “buy” rating in a research report on Tuesday, June 27th. Finally, Goldman Sachs Group, Inc. (The) set a CHF 335 target price on Roche Holding and gave the company a “buy” rating in a research note on Tuesday, June 27th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and eight have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of CHF 267.53.
Shares of Roche Holding (VTX:ROG) opened at 249.60 on Monday. The stock has a 50 day moving average of CHK 244.22 and a 200 day moving average of CHK 251.61. Roche Holding has a 1-year low of CHK 218.30 and a 1-year high of CHK 273.00. The company has a market cap of CHK 212.97 billion and a price-to-earnings ratio of 22.16.
TRADEMARK VIOLATION NOTICE: This piece of content was posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/j-p-morgan-chase-co-reiterates-buy-rating-for-roche-holding-ltd-rog/1606347.html.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.